X4 Pharmaceuticals
(NASDAQ:XFOR)
$1.34
-0.07[-4.96%]
At close: Mar 28
$1.34
0[0.00%]
After Hours: 4:35PM EDT
Q4 2023 Earnings were released on Thu Mar 21st, before the market open
The most recent conference call was at 8:30 AM, 7 days ago Click to view past webcast
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$1.00
Consensus Price Target1
$4.00

X4 Pharmaceuticals Stock (NASDAQ:XFOR), Analyst Ratings, Price Targets, Predictions

X4 Pharmaceuticals Inc has a consensus price target of $4, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., B. Riley Securities, and HC Wainwright & Co. on March 22, 2024, December 12, 2023, and August 11, 2023. With an average price target of $2.33 between HC Wainwright & Co., B. Riley Securities, and HC Wainwright & Co., there's an implied 74.13% upside for X4 Pharmaceuticals Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Dec 23
1
Mar
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
B. Riley Securities
Stifel
B. Riley Securities
Oppenheimer

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for X4 Pharmaceuticals

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/22/2024XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%HC Wainwright & Co.
Swayampakula Ramakanth
→ $3ReiteratesBuy → BuyGet Alert
12/12/2023XFORBuy Now
X4 Pharmaceuticals
$1.34-25.37%B. Riley Securities
Kalpit Patel
$3 → $1DowngradeBuy → NeutralGet Alert
08/11/2023XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%HC Wainwright & Co.
Swayampakula Ramakanth
→ $3ReiteratesBuy → BuyGet Alert
05/17/2023XFORBuy Now
X4 Pharmaceuticals
$1.34273.13%Stifel
Stephen Willey
$4 → $5MaintainsBuyGet Alert
05/05/2023XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%HC Wainwright & Co.
Swayampakula Ramakanth
→ $3Reiterates → BuyGet Alert
04/10/2023XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%B. Riley Securities
Mayank Mamtani
$7 → $3MaintainsBuyGet Alert
03/24/2023XFORBuy Now
X4 Pharmaceuticals
$1.34198.51%Oppenheimer
Leland Gershell
$5 → $4MaintainsOutperformGet Alert
03/22/2023XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%Cantor Fitzgerald
Kristen Kluska
→ $3MaintainsOverweightGet Alert
03/22/2023XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%HC Wainwright & Co.
Swayampakula Ramakanth
$5 → $3MaintainsBuyGet Alert
12/22/2022XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%Cantor Fitzgerald
Kristen Kluska
→ $3Initiates → OverweightGet Alert
12/12/2022XFORBuy Now
X4 Pharmaceuticals
$1.34123.88%Piper Sandler
Edward Tenthoff
→ $3Initiates → OverweightGet Alert
11/30/2022XFORBuy Now
X4 Pharmaceuticals
$1.34273.13%HC Wainwright & Co.
Swayampakula Ramakanth
$3.5 → $5MaintainsBuyGet Alert
05/19/2022XFORBuy Now
X4 Pharmaceuticals
$1.34422.39%B. Riley Securities
Mayank Mamtani
$10 → $7MaintainsBuyGet Alert
05/13/2022XFORBuy Now
X4 Pharmaceuticals
$1.34534.33%HC Wainwright & Co.
Swayampakula Ramakanth
$11 → $8.5MaintainsBuyGet Alert
04/05/2022XFORBuy Now
X4 Pharmaceuticals
$1.34646.27%Canaccord Genuity
Arlinda Lee
$20 → $10MaintainsBuyGet Alert
12/14/2021XFORBuy Now
X4 Pharmaceuticals
$1.34720.9%HC Wainwright & Co.
Swayampakula Ramakanth
MaintainsBuyGet Alert

FAQ

Q

What is the target price for X4 Pharmaceuticals (XFOR)?

A

The latest price target for X4 Pharmaceuticals (NASDAQ: XFOR) was reported by HC Wainwright & Co. on March 22, 2024. The analyst firm set a price target for $3.00 expecting XFOR to rise to within 12 months (a possible 123.88% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for X4 Pharmaceuticals (XFOR)?

A

The latest analyst rating for X4 Pharmaceuticals (NASDAQ: XFOR) was provided by HC Wainwright & Co., and X4 Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for X4 Pharmaceuticals (XFOR)?

A

There is no last upgrade for X4 Pharmaceuticals.

Q

When was the last downgrade for X4 Pharmaceuticals (XFOR)?

A

The last downgrade for X4 Pharmaceuticals Inc happened on December 12, 2023 when B. Riley Securities changed their price target from $3 to $1 for X4 Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for X4 Pharmaceuticals (XFOR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of X4 Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for X4 Pharmaceuticals was filed on March 22, 2024 so you should expect the next rating to be made available sometime around March 22, 2025.

Q

Is the Analyst Rating X4 Pharmaceuticals (XFOR) correct?

A

While ratings are subjective and will change, the latest X4 Pharmaceuticals (XFOR) rating was a reiterated with a price target of $0.00 to $3.00. The current price X4 Pharmaceuticals (XFOR) is trading at is $1.34, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch